ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 162 filers reported holding ANTARES PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $16,000 | +6.7% | 4,000 | -1.9% | 0.00% | – |
Q4 2021 | $15,000 | -11.8% | 4,077 | -10.4% | 0.00% | – |
Q3 2021 | $17,000 | 0.0% | 4,552 | +13.8% | 0.00% | – |
Q2 2021 | $17,000 | -100.0% | 4,000 | -79.8% | 0.00% | -100.0% |
Q1 2021 | $81,378,000 | +508512.5% | 19,800 | +395.0% | 0.00% | – |
Q4 2020 | $16,000 | +14.3% | 4,000 | -23.1% | 0.00% | – |
Q3 2020 | $14,000 | +133.3% | 5,200 | +120.5% | 0.00% | – |
Q2 2020 | $6,000 | +100.0% | 2,358 | +73.6% | 0.00% | – |
Q1 2020 | $3,000 | 0.0% | 1,358 | +69.8% | 0.00% | – |
Q4 2019 | $3,000 | +200.0% | 800 | +45.5% | 0.00% | – |
Q3 2019 | $1,000 | – | 550 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |